ABUS
Price
$5.12
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
1.01B
60 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$11.39
Change
-$0.18 (-1.56%)
Updated
Sep 11 closing price
Capitalization
1.01B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABUS vs KURA

ABUS vs KURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABUS vs. KURA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABUS is a Hold and KURA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABUS($1.01B) and KURA($1.01B) have the same market capitalization . KURA YTD gains are higher at: 9.625 vs. ABUS (6.445). ABUS has higher annual earnings (EBITDA): 153M vs. KURA (-293.98M). KURA has more cash in the bank: 519M vs. ABUS (92.6M). ABUS has less debt than KURA: ABUS (514K) vs KURA (24.5M). ABUS has higher revenues than KURA: ABUS (182M) vs KURA (77.2M).
ABUSKURAABUS / KURA
Capitalization1.01B1.01B100%
EBITDA153M-293.98M-52%
Gain YTD6.4459.62567%
P/E Ratio6.47N/A-
Revenue182M77.2M236%
Total Cash92.6M519M18%
Total Debt514K24.5M2%
FUNDAMENTALS RATINGS
ABUS vs KURA: Fundamental Ratings
ABUS
KURA
OUTLOOK RATING
1..100
2391
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
1599
PRICE GROWTH RATING
1..100
4137
P/E GROWTH RATING
1..100
22100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABUS's Valuation (62) in the Biotechnology industry is in the same range as KURA (64). This means that ABUS’s stock grew similarly to KURA’s over the last 12 months.

ABUS's Profit vs Risk Rating (59) in the Biotechnology industry is somewhat better than the same rating for KURA (100). This means that ABUS’s stock grew somewhat faster than KURA’s over the last 12 months.

ABUS's SMR Rating (15) in the Biotechnology industry is significantly better than the same rating for KURA (99). This means that ABUS’s stock grew significantly faster than KURA’s over the last 12 months.

KURA's Price Growth Rating (37) in the Biotechnology industry is in the same range as ABUS (41). This means that KURA’s stock grew similarly to ABUS’s over the last 12 months.

ABUS's P/E Growth Rating (22) in the Biotechnology industry is significantly better than the same rating for KURA (100). This means that ABUS’s stock grew significantly faster than KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABUSKURA
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ABUS: $5.12 vs. KURA: $11.39)
Brand notoriety: ABUS and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABUS: 62% vs. KURA: 132%
Market capitalization -- ABUS: $1.01B vs. KURA: $1.01B
ABUS [@Biotechnology] is valued at $1.01B. KURA’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABUS’s FA Score shows that 2 FA rating(s) are green while KURA’s FA Score has 0 green FA rating(s).

  • ABUS’s FA Score: 2 green, 3 red.
  • KURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ABUS is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABUS’s TA Score shows that 3 TA indicator(s) are bullish while KURA’s TA Score has 6 bullish TA indicator(s).

  • ABUS’s TA Score: 3 bullish, 6 bearish.
  • KURA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KURA is a better buy in the short-term than ABUS.

Price Growth

ABUS (@Biotechnology) experienced а -0.58% price change this week, while KURA (@Biotechnology) price change was -14.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ABUS is expected to report earnings on Nov 11, 2026.

KURA is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABUS
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRAAX64.280.67
+1.05%
Neuberger Quality Equity A
SEUIX30.65N/A
N/A
SEI Large Cap Value I (SIMT)
LGSCX16.08N/A
N/A
Franklin U.S. Small Cap Equity FI
JSJAX15.35N/A
N/A
JHancock Small Cap Dynamic Growth A
RERCX62.23-0.22
-0.35%
American Funds EUPAC R-3

ABUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with ARRY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
N/A
ARRY - ABUS
43%
Loosely correlated
+1.54%
AXON - ABUS
42%
Loosely correlated
+0.10%
KURA - ABUS
42%
Loosely correlated
-1.56%
RCKT - ABUS
42%
Loosely correlated
-3.74%
MGTX - ABUS
41%
Loosely correlated
-0.47%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with IMVT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-1.56%
IMVT - KURA
52%
Loosely correlated
-1.94%
XNCR - KURA
52%
Loosely correlated
+0.62%
VKTX - KURA
50%
Loosely correlated
-0.47%
VIR - KURA
49%
Loosely correlated
+0.38%
RLAY - KURA
48%
Loosely correlated
-0.11%
More